As an Australian Hemp Company, our mission is to improve the lives of individuals and families globally, through providing access to high quality, therapeutic, plant-based cannabinoid products.
SEED-TO-SHELF QUALITY PROCESS:
Ananda Hemp controls the entire process of production from seed to shelf, which includes over 30+ quality check points to ensure quality and safety of all products for patients. Every batch is 3rd party tested for quality, potency, solvents. pesticides. microbials and heavy metals to provide full transparency to patients and their doctors.
ANANDA PRODUCT OVERVIEW
INSTRUCTIONS FOR USE (intra-vaginal):
Align applicator opening with product nozzle. Squeeze tube to fill applicator with 2-3 grams of Endo Relief Cream. The applicator can be inserted while seated, standing, or reclining, whichever is most comfortable. Gently insert the applicator into vagina and fully compress the plunger to release the cream. After each use, pull the two pieces of the applicator apart and wash with soap and warm water. Dry the pieces and reJoin by gently pushing them back together. For best absorption, lie down for 10 minutes or use at bedtime. When using for intimate moments, apply 10 minutes before sexual activity for best results.
STORAGE: Store at room temperacture (18-25° C) out of direct sunlight, when not in use. Refrigerate (2-8° C) 30 minutes prior to use.
SIDE EFFECTS: Potential side effects include somnolence. diarrhoea. heartburn. sleep disturbances. dizziness. rash. dry mouth, and change in appetite. Frequency of side effects is expected to be rare with intravaginal delivery.
BACKGROUND EDUCATION
WHAT IS THE ENDOCANNABINOID SYSTEM (ECS)?
The Endocannabinoid System (ECS) is a network of receptors present throughout the central and peripheral nervous systems as well as on many organs and organ systems. Two main receptor types. CB1 and CB2. comprise the ECS. CB1 receptors are abundant in nervous tissue and are the most abundant in the brain. CB2 receptors are present in the brain, but are more localised throughout the periphery and particularly on immune and lymphatic cells. Through CB1 and CB2 receptors. the ECS infiuences balance or homeostatic function via multiple mechanisms of action, impacting immune responses. infiammation, appetite, metabolism. pain perception, muscle relaxation, mood, motor control & coordination and more.
WHAT IS FULL SPECTRUM HEMP (CANNABIDIOL)?
Full Spectrum hemp is a cannabidiol (CBD) rich extract derived from the fiower of the cannabis sativa hemp plant. Full Spectrum means that in addition to CBD, the extract contains other phytocompounds naturally found in the hemp plant. One compound that is always included in Full Spectrum Hemp is THC. or tetrahydro cannabinol. THC is intoxicating in high doses. but it is found in very low concentrations of 0.3% or less in Ananda Hemp extracts.
HOW DO CANNABINOIDS EFFECT DYSMENNORHEA, VULVODYNIA, DYSPAREUNIA, ENDOMETRIOSIS, VAGINISMUS, AND PRE MENSTRUAL SYNDROME?
Endocannabinoid receptors are abundant in female reproductive organs and the central nervous system. Their signaling infiuences multiple physiological and pathophysiological functions of female reproduction. including folliculogenesis, endometrial cell motility, endometrial migration and proliferation, and peripheral innervation associated with endometrial and pelvic pain. Cannabinoid agonists exert antiproliferative effects on deep infiltrating endometriosis. and increased cannabinoid signaling may reduce proliferation of endometriotic lesions. Cannabinoid receptors in the pelvis, ovaries, endometrium, vulva and the central and peripheral nervous systems influence infiammation, nociception and arousal at these therapeutic targets. Cannabinoids trigger localised vasodilation and relaxation of pathological smooth muscle contraction and/or spasticity.
CLINICAL TRIALS FOR ANANDA HEMP EXTRACT:
Ananda Hemp Extracts have been used in an open-label prospective study evaluating their effects on opioid use, chronic pain, and sleep quality among a single cohort of chronic pain patients.
- CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY AMONG BREAST, COLON, UTERINE, AND OVARIAN CANCER PATIENTS
- AGITATION IN ALZHEIMER'S DEMENTIA PATIENTS
- SLEEP DISTURBANCES
- LESION PROLIFERATION AND INNERVATION ON WOMEN WITH ENDOMETRIOSIS